BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright ©The Author(s) 2026.
World J Orthop. Feb 18, 2026; 17(2): 115188
Published online Feb 18, 2026. doi: 10.5312/wjo.v17.i2.115188
Table 1 Pre-matching and post-matching standardized mean differences and characteristics of elderly total knee arthroplasty patients with preoperative frailty and non-frail cohort
Characteristic
Frail pre-match (n = 612)
Non-frail pre-match (n = 2512)
SMD pre-match
Frail post-match (n = 512)
Non-frail post-match (n = 2048)
SMD post-match
Age (mean ± SD)73.5 ± 5.571.2 ± 4.80.4572.3 ± 5.172.1 ± 4.90.04
Gender: Female (%)65.058.00.1460.960.40.01
Body mass index (mean ± SD)32.1 ± 4.229.8 ± 3.90.5630.5 ± 4.030.4 ± 3.90.03
American Society of Anesthesiologists III and IV (%)45.025.00.4230.129.00.02
Diabetes mellitus (%)55.035.00.4140.640.10.01
Hypertension (%)80.060.00.4369.969.50.01
Chronic obstructive pulmonary disease (%)30.015.00.3519.920.00.00
Table 2 Ninety-day postoperative complications between elderly total knee arthroplasty patients with preoperative frailty and a matched-control cohort
Complication
Frailty (%)
Control (%)
Odds ratio
95%CI
P value
Composite21.19.22.612.05-3.32< 0.001
Surgical site infection5.31.83.122.18-4.46< 0.001
Deep vein thrombosis4.11.52.851.92-4.23< 0.001
Pulmonary embolism3.71.04.022.45-6.59< 0.001
Periprosthetic fracture2.00.82.561.45-4.520.001
Table 3 Healthcare utilization between elderly total knee arthroplasty patients with preoperative frailty and a matched-control cohort
Utilization
Frailty
Control
Odds ratio
95%CI
P value
Readmission (%)17.04.24.743.56-6.31< 0.001
Length of stay (days), mean ± SD)5.6 ± 1.93.9 ± 1.5--< 0.001
Table 4 One-year functional recovery (Knee Society Score) between elderly total knee arthroplasty patients with preoperative frailty and a matched-control cohort
Outcome
Frailty (mean ± SD)
Control (mean ± SD)
P value
Baseline KSS45.2 ± 9.846.1 ± 9.40.312
1-year KSS75.5 ± 10.285.1 ± 8.1< 0.001
Delta KSS30.3 ± 11.439.0 ± 10.2< 0.001